ADVANCED ENDOMETRIAL CARCINOMA
Clinical trials for ADVANCED ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new daily pill, NKT3964, in adults with advanced solid tumors (like ovarian, endometrial, breast, lung, or stomach cancer) that have stopped responding to standard treatments. The main goals are to check the drug's safety and find the best dose, whi…
Matched conditions: ADVANCED ENDOMETRIAL CARCINOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Electric field device joins drug combo to fight advanced cancers
Disease control Recruiting nowThis early-phase study tests a wearable device that creates electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The goal is to see i…
Matched conditions: ADVANCED ENDOMETRIAL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New drug cocktail shows promise for Tough-to-Treat endometrial cancer
Disease control Recruiting nowThis study tests whether adding a drug called bevacizumab to standard chemotherapy plus immunotherapy works better for advanced or recurrent endometrial cancer with specific genetic changes (pMMR and TP53 mutated). About 255 participants will receive one of three treatment combin…
Matched conditions: ADVANCED ENDOMETRIAL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC